Experimental Data Snapshot
wwPDB Validation  3D Report Full Report
(1995) J Mol Biology 254: 62-76
In order to understand the contribution of hydrophobic residues to the conformational stability of human lysozyme, five Ile mutants (Ile --> Val) in the interior of the protein were constructed. The thermodynamic parameters characterizing the denaturation of these mutant proteins were determined by scanning calorimetry, and the three-dimensional structure of each mutant protein was solved at high resolution by X-ray crystallography. The thermodynamic analyses at 64.9 degrees C and at pH 2.7 revealed the following. (1) The stabilities of all the mutant proteins were decreased as compared with that of the wild-type protein. (2) The changes in the calorimetric enthalpies were larger than those in the Gibbs energies, and were compensated by entropy changes. (3) The destabilization mechanism of the mutant proteins differs, depending on the location of the mutation sites. X-ray analyses showed that the overall structures of all the mutant human lysozymes examined were identical to that of the wild-type protein, and only small structural rearrangements were observed locally around some of the mutation sites. The most striking change among the mutant proteins was found in the mutant protein, 159V, which contains a new water molecule in the cavity created by the mutation. The thermodynamic stabilities of the mutant proteins are discussed in light of the high-resolution X-ray structures of the wild-type and five mutant human lysozymes examined.
 Explore in 3D: Structure |Sequence Annotations |Validation Report |Ligand Interaction (NA)
Biological assembly 1 assigned by authors.
Macromolecule Content 
Entity ID: 1 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| LYSOZYME | 130 | Homo sapiens | Mutation(s): 1  Gene Names: HUMAN LYSOZYME WITH ILE 106 EC: 3.2.1.17 | ![]() | |
UniProt & NIH Common Fund Data Resources | |||||
Find proteins for P61626 (Homo sapiens) Explore P61626  Go to UniProtKB:  P61626 | |||||
PHAROS:  P61626 GTEx:  ENSG00000090382  | |||||
Entity Groups  | |||||
| Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
| UniProt Group | P61626 | ||||
Sequence AnnotationsExpand | |||||
| |||||
| Ligands 1 Unique | |||||
|---|---|---|---|---|---|
| ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
| NA Query on NA Download Ideal Coordinates CCD File  | B [auth A] | SODIUM ION Na FKNQFGJONOIPTF-UHFFFAOYSA-N | |||
| Length ( Å ) | Angle ( ˚ ) |
|---|---|
| a = 56.764 | α = 90 |
| b = 61.05 | β = 90 |
| c = 33.801 | γ = 90 |
| Software Name | Purpose |
|---|---|
| PROCESS | data collection |
| X-PLOR | model building |
| X-PLOR | refinement |
| PROCESS | data reduction |
| X-PLOR | phasing |
RCSB PDB Core Operations are funded by theU.S. National Science Foundation (DBI-2321666), theUS Department of Energy (DE-SC0019749), and theNational Cancer Institute,National Institute of Allergy and Infectious Diseases, andNational Institute of General Medical Sciences of theNational Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.